Mayo Clinic to lead a new radiotracer trial for detecting pancreatic cancer

Mayo Clinic to lead a new radiotracer trial for detecting pancreatic cancer

Newswise — ROCHESTER, Minn. — In an academic-industrial collaboration, the Mayo Clinic is assessing in a clinical trial a new radiotracer in pancreatic cancer imaging.

As part of the investigation, the new agent, 68Ga-Fibroblast-Activation-Protein-Inhibitors (FAPI)-46 (68Ga-FAPI-46), will be